Committee moves two bills on cell-cultured proteins and labeling forward after debate on science and litigation risks

Representative Shamhorn presented two related sale bills aimed at protecting livestock producers and consumer transparency. The first would prohibit sale of certain cell-cultured protein products in the state; the second would require clear labeling, using a specified font size standard (noted as 30-point in testimony), where cell-cultured content is commingled with other products.

Commissioner Strain described the state-level approach as precautionary, and warned that opponents will likely litigate; he cited recent federal appellate decisions, noting the Eleventh Circuit upheld a Florida ban on narrow statutory grounds and that litigation could hinge on dormant commerce clause and federal preemption questions. The author and commissioner emphasized that the bills carve out research exceptions for universities and research centers.

Members asked whether the measures would affect food-safety research or commercial production; the author said research at universities would be allowed and that labeling standards mirror requirements already used for seafood. Senator Fezzi asked that the committee avoid language that would trigger federal preemption, and the sponsor said the bills were drafted with court risk in mind.

After discussion, Senator Faizy moved to report House Bill 512 favorably; the committee reported HB 512 and the related labeling measure (HB 717) favorably by voice with no recorded opposition.